Marsh & Mclennan Companies, Inc. (MRSH): price, analyst ratings, earnings and fundamentals
Updated 16 September 2026, 08:02 ET
Marsh & Mclennan Companies, Inc. (MRSH) closed at $179.76 on 15 September 2026, down 0.4%. The stock is down 4.3% over one month. It trades 9.4% below its 52-week high of $198.49. Analysts recorded 11 actions in the last 90 days; the median price target of $202 is 12.4% above the last close. The company last reported on 21 July 2026 for Q2 2026: EPS of $2.96 against an estimate of $2.90, a beat of 2.1%, on revenue of $7.4 billion.
Price and performance
Performance figures use dividend and split adjusted closes over trading sessions, so a one-year move compares the last close with the close 252 sessions earlier. The 52-week range uses the adjusted daily highs and lows of the same window. Read the guide: Momentum, trend and technical indicators.
The live chart with technical indicators is in the app: open MRSH in FundSpec.
Analyst ratings
Over the last 90 days FundSpec recorded 11 analyst actions on MRSH from 8 firms: 10 maintained or reiterated a view and 1 downgrade. Price targets were 8 raised and 2 lowered. The most recent targets from 12 firms range from $174 to $234, with a median of $202, 12.4% above the last close.
| Date | Firm | Action | Price target |
|---|---|---|---|
| 19 Aug 2026 | Morgan Stanley | Maintains Equal-Weight | $180.00 to $200.00 |
| 27 Jul 2026 | UBS | Maintains Buy | $212.00 to $216.00 |
| 22 Jul 2026 | Wells Fargo | Maintains Equal-Weight | $186.00 to $188.00 |
| 22 Jul 2026 | Mizuho | Maintains Neutral | $197.00 to $201.00 |
| 22 Jul 2026 | Citigroup | Downgrades to Neutral from Buy | $200.00 |
| 13 Jul 2026 | JP Morgan | Maintains Overweight | $206.00 to $212.00 |
| 10 Jul 2026 | Evercore ISI Group | Maintains Outperform | $236.00 to $234.00 |
| 9 Jul 2026 | Cantor Fitzgerald | Maintains Overweight | $210.00 to $218.00 |
| 9 Jul 2026 | Mizuho | Maintains Neutral | $194.00 to $197.00 |
| 8 Jul 2026 | UBS | Maintains Buy | $203.00 to $212.00 |
A price target is one firm's twelve-month view, and the median across firms is a steadier reading than any single call. Upgrades and downgrades matter more when they change a rating, not only a target. Read the guide: What analyst ratings and price targets actually tell you.
Every action with the firm's history is in Analyst Ratings.
Earnings
The next report is scheduled for 15 October 2026 before the open for Q3 2026, with EPS expected at $1.97 on revenue of $6.6 billion. Marsh & Mclennan Companies, Inc. beat the EPS estimate in 8 of its last 8 reported quarters.
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | 21 Jul 2026 | $2.90 | $2.96 | +2.07% | $7.4B |
| Q1 2026 | 16 Apr 2026 | $3.22 | $3.29 | +2.17% | $7.6B |
| Q4 2025 | 29 Jan 2026 | $1.97 | $2.12 | +7.61% | $6.6B |
| Q3 2025 | 16 Oct 2025 | $1.78 | $1.85 | +3.93% | $6.4B |
| Q2 2025 | 17 Jul 2025 | $2.67 | $2.72 | +1.87% | $7.0B |
| Q1 2025 | 17 Apr 2025 | $3.00 | $3.06 | +2.00% | $7.1B |
| Q4 2024 | 30 Jan 2025 | $1.76 | $1.87 | +6.25% | $6.1B |
| Q3 2024 | 17 Oct 2024 | $1.61 | $1.63 | +1.24% | $5.7B |
An earnings surprise is the reported EPS against the consensus estimate on the day. The price reaction depends as much on guidance and on what was already priced in as on the surprise itself. Read the guide: Earnings season: estimates, surprises and price reaction.
Estimates, confirmed dates and alerts for every company are in Earnings.
Fundamentals
On a trailing twelve month basis the company shows revenue growth of N.A., a gross margin of N.A., an operating margin of N.A. and a return on equity of N.A..
Margins and returns say how much of each dollar of sales becomes profit and how hard the balance sheet is working; leverage and liquidity say how much room the company has when conditions turn. Read the guide: A practical guide to discounted cash flow valuation.
Fair value, peer multiples and the full statement history are in the app: open MRSH in FundSpec.
SEC filings
The latest filing is a 10-Q from 21 July 2026.
| Filed | Form | Document |
|---|---|---|
| 21 Jul 2026 | 10-Q | View on sec.gov |
| 16 Apr 2026 | 10-Q | View on sec.gov |
| 9 Feb 2026 | 10-K | View on sec.gov |
| 16 Oct 2025 | 10-Q | View on sec.gov |
| 17 Jul 2025 | 10-Q | View on sec.gov |
| 17 Apr 2025 | 10-Q | View on sec.gov |
| 10 Feb 2025 | 10-K | View on sec.gov |
| 17 Oct 2024 | 10-Q | View on sec.gov |
| 18 Jul 2024 | 10-Q | View on sec.gov |
| 18 Apr 2024 | 10-Q | View on sec.gov |
Company profile
- Exchange
- NYSE
- Sector
- Finance, Insurance, And Real Estate
- Industry
- Insurance
- Headquarters
- New York, New York
- Chief executive
- Daniel S. Glaser
- Employees
- 85,000
- Website
- mmc.com
- SEC CIK
- 0000062709
Marsh & McLennan Companies, Inc. provides advice and solutions to clients in the areas of risk, strategy, and people worldwide. The Risk and Insurance Services segment offers risk management services, such as risk advice, risk transfer, and risk control and mitigation solutions. The Consulting segment provides health, wealth, and career consulting services.
Sector and peers
Marsh & Mclennan Companies, Inc. is part of the Finance, Insurance, And Real Estate sector, which FundSpec tracks across 1 company.
In FundSpec: the fair value estimate, the momentum reading, relative valuation against sector and industry peers, unusual options activity and AI model signals for MRSH are available to subscribers, with the same screen in the iOS and Android apps.
Open MRSH in FundSpec